330 related articles for article (PubMed ID: 28948376)
1. Genetic diversity and macrolide resistance of Mycoplasma pneumoniae isolates from two consecutive epidemics in Slovenia.
Kogoj R; Praprotnik M; Mrvič T; Korva M; Keše D
Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):99-107. PubMed ID: 28948376
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, genotyping and macrolide resistance of Mycoplasma pneumoniae among isolates of patients with respiratory tract infections, Central Slovenia, 2006 to 2014.
Kogoj R; Mrvic T; Praprotnik M; Kese D
Euro Surveill; 2015; 20(37):. PubMed ID: 26536357
[TBL] [Abstract][Full Text] [Related]
3. Emergence of Macrolide-Resistant Mycoplasma pneumoniae in Hong Kong Is Linked to Increasing Macrolide Resistance in Multilocus Variable-Number Tandem-Repeat Analysis Type 4-5-7-2.
Ho PL; Law PY; Chan BW; Wong CW; To KK; Chiu SS; Cheng VC; Yam WC
J Clin Microbiol; 2015 Nov; 53(11):3560-4. PubMed ID: 26338857
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of Mycoplasma pneumoniae infections in Moscow from 2015 to 2018.
Voronina EN; Gordukova MA; Turina IE; Mishukova OV; Dymova MA; Galeeva EV; Korsunskiy AA; Filipenko ML
Eur J Clin Microbiol Infect Dis; 2020 Feb; 39(2):257-263. PubMed ID: 31655931
[TBL] [Abstract][Full Text] [Related]
5. First Detection and Characterization of Macrolide-Resistant
Noori Goodarzi N; Pourmand MR; Arfaatabar M; Azimi G; Masoorian E; Rahimi Foroushani A; Aminharati F; Heidarzadeh S; Baghani A
Microb Drug Resist; 2020 Mar; 26(3):245-250. PubMed ID: 31545147
[No Abstract] [Full Text] [Related]
6. Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015.
Tanaka T; Oishi T; Miyata I; Wakabayashi S; Kono M; Ono S; Kato A; Fukuda Y; Saito A; Kondo E; Teranishi H; Tanaka Y; Wakabayashi T; Akaike H; Ogita S; Ohno N; Nakano T; Terada K; Ouchi K
Emerg Infect Dis; 2017 Oct; 23(10):1703-1706. PubMed ID: 28930026
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization and analysis of Mycoplasma pneumoniae among patients of all ages with community-acquired pneumonia during an epidemic in China.
Qu J; Chen S; Bao F; Gu L; Cao B
Int J Infect Dis; 2019 Jun; 83():26-31. PubMed ID: 30926541
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the molecular characteristics of Mycoplasma pneumoniae from children across different regions of China.
Xue G; Li M; Wang N; Zhao J; Wang B; Ren Z; Yan C; Wu C; Liu Y; Sun H; Xu M; Sun H
PLoS One; 2018; 13(8):e0198557. PubMed ID: 30138360
[TBL] [Abstract][Full Text] [Related]
9. Molecular Typing of
Gullsby K; Olsen B; Bondeson K
J Clin Microbiol; 2019 Jun; 57(6):. PubMed ID: 30918047
[No Abstract] [Full Text] [Related]
10. First Description of Macrolide-Resistant
Loconsole D; De Robertis AL; Mallamaci R; Sallustio A; Morea A; Prato R; Quarto M; Martinelli D; Chironna M
Biomed Res Int; 2019; 2019():7168949. PubMed ID: 31008110
[TBL] [Abstract][Full Text] [Related]
11. Multiple-Locus Variable-Number Tandem-Repeat Analysis of Mycoplasma pneumoniae Isolates between 2004 and 2014 in Yamagata, Japan: Change in Molecular Characteristics during an 11-year Period.
Suzuki Y; Seto J; Shimotai Y; Itagaki T; Katsushima Y; Katsushima F; Ikeda T; Mizuta K; Hongo S; Matsuzaki Y
Jpn J Infect Dis; 2017 Nov; 70(6):642-646. PubMed ID: 29093323
[TBL] [Abstract][Full Text] [Related]
12. Diversity in Genotype Distribution of Mycoplasma pneumoniae Obtained from Children and Adults.
Yan C; Yang H; Sun H; Zhao H; Feng Y; Xue G; Li S; Cui J; Ni S
Jpn J Infect Dis; 2020 Jan; 73(1):14-18. PubMed ID: 31474699
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients.
Kawai Y; Miyashita N; Yamaguchi T; Saitoh A; Kondoh E; Fujimoto H; Teranishi H; Inoue M; Wakabayashi T; Akaike H; Ogita S; Kawasaki K; Terada K; Kishi F; Ouchi K
Respirology; 2012 Feb; 17(2):354-62. PubMed ID: 22077195
[TBL] [Abstract][Full Text] [Related]
14. Multiple-locus variable-number tandem-repeat analysis (MLVA) of macrolide-susceptible and -resistant Mycoplasma pneumoniae in children in Taiwan.
Lu CY; Yen TY; Chang LY; Liau YJ; Liu HH; Huang LM
J Formos Med Assoc; 2020 Oct; 119(10):1539-1545. PubMed ID: 31924377
[TBL] [Abstract][Full Text] [Related]
15. Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000-2011.
Hong KB; Choi EH; Lee HJ; Lee SY; Cho EY; Choi JH; Kang HM; Lee J; Ahn YM; Kang YH; Lee JH
Emerg Infect Dis; 2013 Aug; 19(8):1281-4. PubMed ID: 23876792
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and mechanism of drug resistance of Mycoplasma pneumoniae in Beijing, China: A multicenter study.
Guo DX; Hu WJ; Wei R; Wang H; Xu BP; Zhou W; Ma SJ; Huang H; Qin XG; Jiang Y; Dong XP; Fu XY; Shi DW; Wang LY; Shen AD; Xin DL
Bosn J Basic Med Sci; 2019 Aug; 19(3):288-296. PubMed ID: 30878034
[TBL] [Abstract][Full Text] [Related]
17. Multiclonal origin of macrolide-resistant Mycoplasma pneumoniae isolates as determined by multilocus variable-number tandem-repeat analysis.
Liu Y; Ye X; Zhang H; Xu X; Wang M
J Clin Microbiol; 2012 Aug; 50(8):2793-5. PubMed ID: 22649013
[TBL] [Abstract][Full Text] [Related]
18. Characterization of macrolide resistance of Mycoplasma pneumoniae in children in Shenzhen, China.
Ma Z; Zheng Y; Deng J; Ma X; Liu H
Pediatr Pulmonol; 2014 Jul; 49(7):695-700. PubMed ID: 23861188
[TBL] [Abstract][Full Text] [Related]
19.
Dou HW; Tian XJ; Xin L; Wei R; Zhou W; Wang H; Qin XG; Shao JY; Xu BP; Ge LX; Shi DW
Biomed Environ Sci; 2020 Dec; 33(12):916-924. PubMed ID: 33472731
[TBL] [Abstract][Full Text] [Related]
20. Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae by pyrosequencing.
Spuesens EB; Hoogenboezem T; Sluijter M; Hartwig NG; van Rossum AM; Vink C
J Microbiol Methods; 2010 Sep; 82(3):214-22. PubMed ID: 20547188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
